We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1911:TSEChina Renaissance Holdings Limited Analysis

Data as of 2026-03-11 - not real-time

HK$3.74

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

China Renaissance (1911.HK) is trading at HK$3.74, just above the calculated support of HK$3.63 and well below the resistance of HK$4.76. Technicals are clearly bearish: the 20‑day SMA (4.16) sits below the 50‑day SMA (4.31) and both are under the 200‑day SMA (5.42); the MACD line is negative and its histogram is shrinking, while the RSI at 38 hints at modest oversold pressure. Volume is on a downtrend and 30‑day volatility is exceptionally high at ~65%, suggesting erratic price swings. On the valuation side, the forward P/E of 2.85 is dramatically lower than the industry average of 17, and the price‑to‑book of 0.31 versus a book value of HK$12.09 per share signals a deep discount. The company holds HK$5.18 bn in cash against HK$0.51 bn of debt, giving it a strong liquidity buffer despite negative operating cash flow and a trailing loss. Market sentiment is in "Extreme Greed" (fear‑greed index 75.75) and analysts project a median target of HK$12.76, implying a potential upside of over 200%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above technical support
  • Bearish moving‑average alignment and negative MACD
  • High short‑term volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Substantial cash cushion versus modest debt
  • Forward earnings estimate yielding a low P/E of 2.85
  • Analyst target price suggesting >200% upside

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential turnaround in profitability with new‑economy advisory focus
  • Deep discount to book value and strong balance sheet
  • Long‑run exposure to China’s growing financial services sector

Key Metrics & Analysis

Financial Health

Revenue Growth44.70%
Profit Margin-4.10%
P/E Ratio2.9
ROE-0.82%
ROA-0.62%
Debt/Equity7.23
P/B Ratio0.3
Op. Cash FlowHK$-76849000
Industry P/E17.1

Technical Analysis

TrendBearish
RSI38.0
SupportHK$3.63
ResistanceHK$4.76
MA 20HK$4.16
MA 50HK$4.31
MA 200HK$5.42
MACDBearish
VolumeDecreasing
Fear & Greed Index75.75

Valuation

Target PriceHK$12.76
Upside/Downside241.26%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.17
Volatility64.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.